Forum: Articles of Interest
11-16-2014, 09:45 AM
|
Replies: 1
Views: 21,634
Re: Coming treatments: Pfizer's Palbociclib
HER2 Positive Breast Cancer Drug Market to 2023: US, China and Japan Analysis With Forecasts
Share with LinkedIn
DALLAS, October 22, 2014 /PRNewswire/ --
RnRMarketResearch.com...
|
Forum: Articles of Interest
11-16-2014, 09:42 AM
|
Replies: 1
Views: 21,634
Coming treatments: Pfizer's Palbociclib
Although this is in trials for Er+ Her2- it is one to watch for breast cancer.
Palbociclib (PD-0332991)
Target: Inhibitor of cyclin-dependent kinases (CDK) 4 and 6
Disease focus: Metastatic...
|